Previous close | 322.40 |
Open | 322.40 |
Bid | 324.80 x 0 |
Ask | 325.10 x 0 |
Day's range | 317.50 - 327.90 |
52-week range | 248.00 - 704.80 |
Volume | |
Avg. volume | 1,096,212 |
Market cap | 136.582B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | N/A |
EPS (TTM) | -49.71 |
Earnings date | 30 Jan 2024 - 05 Feb 2024 |
Forward dividend & yield | 13.50 (4.19%) |
Ex-dividend date | 08 Mar 2023 |
1y target est | 405.52 |
Denmark's Orsted said on Thursday it has been granted a 1.6 gigawatt (GW) electricity business licence (EBL) in South Korea for an offshore wind project located 70 km (43 miles) off the coast of Incheon City. Subject to a final investment decision, the project is expected to be South Korea's largest offshore wind project when completed in the early 2030s, Orsted said. The project will support Incheon's net-zero carbon emissions goal with a capacity to provide renewable energy to over a million households while reducing the emissions by some 4 million tonnes annually, the company said in a statement.
HELSINKI (Reuters) -Denmark's Orsted said on Tuesday its finance and operations chiefs were stepping down with immediate effect after the offshore wind farm developer earlier this month reported large financial losses due to delays with U.S. projects. The offshore wind industry has found itself in a perfect storm of rising inflation, interest rate hikes and delays in the supply chain struggling to cope with growing demand. "Orsted, along with the rest of the industry, is experiencing a challenging and volatile business environment," CEO Mads Nipper said in a statement.
(Bloomberg) -- The UK government is preparing to offer significantly higher subsidies for new offshore wind farms to get the country’s clean-power strategy back on track after developers shunned a previous auction. Most Read from BloombergRockstar Plans to Announce Much Anticipated ‘Grand Theft Auto VI’Two-Year Yield Tops 5% on Powell’s ‘Sterner’ Tone: Markets WrapSaudis Find a Bottomless Money Pit in LucidIsrael Latest: US Says Forces Attacked Again After Syria StrikeNew Ozempic Rival Is About